Effects of ICD implantation on quality-adjusted life years in patients with congestive heart failure

被引:4
|
作者
Ozasa, Neiko [2 ]
Morimoto, Takeshi [1 ]
Furukawa, Yutaka [2 ]
Shizuta, Satoshi [2 ]
Nishiyama, Kei [2 ]
Kita, Toru [2 ]
Kimura, Takeshi [2 ]
机构
[1] Kyoto Univ, Grad Sch Med, Ctr Med Educ, Sakyo Ku, Kyoto 6068501, Japan
[2] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan
关键词
decision analysis; implantable cardioverter-defibrillator; primary prevention; quality-adjusted life years; reduced left ventricular ejection fraction;
D O I
10.1016/j.ijcard.2006.11.216
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Effects of prophylactic implantable cardioverter-defibrillator (ICD) on quality-adjusted life years (QALYs) in patients with congestive heart failure are uncertain. Methods: We developed a decision model for patients at risk of sudden death due to reduced ejection fraction and who had no history of life-threatening ventricular arrhythmias. It estimated the QALYs for ICD strategy as a primary prevention for sudden cardiac death and conventional strategy without antiarrhythmic therapies. Results: In a 3-year time period, the QALYs for patients with conventional strategy were higher than that of ICD strategy (2.19 years vs. 2.14 years). When the mortality rate of conventional strategy exceeded 8.6%/year and the hazard ratio of death for the ICD strategy was lower than 0.70, the ICD strategy was the superior treatment option. Conclusions: The QALYs of patients with ICD could be lower than that of conventional strategy. Incorporating quality of life could affect decision making of ICD implantation. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
下载
收藏
页码:213 / 216
页数:4
相关论文
共 50 条
  • [1] Study of CardioMEMS in heart failure patients: Study confirms benefit in costs and quality-adjusted life years, but does not measure quality-adjusted life years
    Messori, Andrea
    Trippoli, Sabrina
    ESC HEART FAILURE, 2024,
  • [2] Quality-adjusted life year weights among elderly patients with heart failure
    Alehagen, Urban
    Rahmqvist, Mikael
    Paulsson, Thomas
    Levin, Lars-Ake
    EUROPEAN JOURNAL OF HEART FAILURE, 2008, 10 (10) : 1033 - 1039
  • [3] QUALITY-ADJUSTED LIFE-YEARS
    SMITH, A
    LANCET, 1987, 2 (8549): : 47 - 47
  • [4] QUALITY-ADJUSTED LIFE-YEARS
    WILLIAMS, A
    LANCET, 1987, 1 (8546): : 1372 - 1372
  • [5] The Value of the Quality-Adjusted Life Years
    Willke, Richard J.
    Pizzi, Laura T.
    Rand, Leah Z.
    Neumann, Peter
    VALUE IN HEALTH, 2024, 27 (06) : 702 - 705
  • [6] QUALITY-ADJUSTED LIFE YEARS - REPLY
    RICHARDSON, J
    SCHWARTZ, S
    AUSTRALIAN JOURNAL OF PUBLIC HEALTH, 1994, 18 (02): : 227 - 228
  • [7] Putting the quality into quality-adjusted life years
    Oliver, A
    JOURNAL OF PUBLIC HEALTH MEDICINE, 2003, 25 (01): : 8 - 12
  • [8] WILLINGNESS TO PAY FOR QUALITY-ADJUSTED LIFE YEARS IN PATIENTS WITH DIABETE
    Moradi, N.
    Rashidian, A.
    VALUE IN HEALTH, 2015, 18 (07) : A617 - A617
  • [9] Fundamental Measurement and Quality-Adjusted Life Years
    Langley, Paul C.
    McKenna, Stephen P.
    VALUE IN HEALTH, 2021, 24 (03) : 461 - 461
  • [10] Not all "quality-adjusted life years" are equal
    Marra, C. A.
    Marion, S. A.
    Guh, D. P.
    Najafzadeh, M.
    Wolfe, F.
    Esdaile, J. M.
    Clarke, A. E.
    Gignac, M. A.
    Anis, A. H.
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2007, 60 (06) : 616 - 624